Holen Sie sich die Stockscreener-App
2.54
3.79%
-0.10
Handel nachbörslich:
2.51
-0.03
-1.18%
Schlusskurs vom Vortag:
$2.64
Offen:
$2.61
24-Stunden-Volumen:
365.79K
Relative Volume:
0.08
Marktkapitalisierung:
$45.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.68%
1M Leistung:
+124.78%
6M Leistung:
-23.95%
1J Leistung:
-33.68%
1-Tages-Spanne:
$2.52
$2.62
1-Wochen-Bereich:
$2.52
$2.68
52-Wochen-Spanne:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.54 | 45.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Layoff Tracker: Pliant Cuts 45% of Staff To Extend Cash Runway - BioSpace
Geode Capital Management LLC Sells 9,027 Shares of Mural Oncology plc (NASDAQ:MURA) - Defense World
Goldman Sachs adjusts positions in Mural Oncology shares By Investing.com - Investing.com Nigeria
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Form 8.3Mural Oncology plc - Business Wire
Goldman Sachs adjusts positions in Mural Oncology shares - Investing.com Australia
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com India
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Renaissance Technologies LLC Boosts Stock Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Ovarian Cancer Market: Epidemiology, Therapies, Companies, - openPR.com
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com India
Goldman Sachs adjusts stake in Mural Oncology - Investing.com
Mural Oncology plc Opening Position Disclosure Under Irish Takeover Rules - Nasdaq
FORM 8.1(a) & (b)Mural Oncology plc - The Manila Times
Mural Oncology Takeover Speculation Heats Up as CEO Stakes Revealed: 900K+ Total Shares - Stock Titan
Tang Capital reports stake in Mural Oncology - Investing.com
March sees multiple phase III successes, boosting Corcept and Mineralys - BioWorld MedTech
LMR Partners reports 2.997% stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology amid takeover rules By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology - Investing.com Australia
BlackRock discloses stake in Mural Oncology amid takeover rules - Investing.com Australia
LMR Partners reports 2.997% stake in Mural Oncology - Investing.com Australia
Tang Capital discloses stake in Mural Oncology By Investing.com - Investing.com India
Tang Capital discloses stake in Mural Oncology - Investing.com
Solas Capital discloses dealings in Mural Oncology shares By Investing.com - Investing.com India
Solas Capital discloses dealings in Mural Oncology shares - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com India
BlackRock reports stake in Mural Oncology - Investing.com Australia
Quarterly Metrics: Quick and Current Ratios for Mural Oncology plc (MURA) - DWinneX
Geode Capital reports 1.02% stake in Mural Oncology By Investing.com - Investing.com South Africa
Largest borrow rate increases among liquid names - TipRanks
Geode Capital reports 1.02% stake in Mural Oncology - Investing.com
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):